Factors limiting subgroup analysis in cost-effectiveness analysis and a call for transparency

Gemma Shields, Mark Robson Wilberforce, Paul Clarkson, Tracey Farragher, Arpana Verma, Linda Davies

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Number of pages8
JournalPharmacoEconomics
Early online date29 Oct 2021
DOIs
Publication statusE-pub ahead of print - 29 Oct 2021

Bibliographical note

© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details

Cite this